Seattle Genetics and Agensys Expand Cancer Collaboration
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 12 (Table of Contents)
Published: 7 Dec-2009
DOI: 10.3833/pdr.v2009.i12.1281 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Seattle Genetics and Agensys, an affiliate of Astellas, have announced the expansion of their 2007 collaboration on antibody-drug conjugates to treat cancer targets. Seattle Genetics gets an upfront payment of US$12 M with the potential to earn up to US$350 M.
Copyright: © IQVIA 2018
RSS